Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ARK Genomic Revolution ETF (ARKG) vs Carvana Co (CVNA) Price & Performance

ARK Genomic Revolution ETFTrade
Carvana CoTrade

Price performance (Past 24H)

Key statistics

ARK Genomic Revolution ETF vs Carvana Co — how do they compare? ARK Genomic Revolution ETF trades at $44.5, while Carvana Co trades at $71.14 (market cap $79.17B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Carvana Co nearer its low. Which is the better fit depends on your goals.

ARKGCVNA
Sector
Sector/ThematicConsumer Cyclical
52-Week High
$44.55$95.69
52-Week Low
$24.02$56.27
Market Cap
$79.17B
Enterprise Value
$81.65B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ARK Genomic Revolution ETF

No Aura AI signal available yet.

Carvana Co

Carvana (CVNA) trades at $70.83, down 4.54% on the day, with a bullish technical signal from moving averages but overbought RSI readings. The company reported record Q2 2026 results with revenue up 52% year-over-year to $7.38 billion and net income of $513 million, though shares fell due to disappointing full-year EBITDA guidance. Strong cash flow generation continues with 2025 operating cash flow of $1.04 billion.

Outlook remains positive with analyst consensus price target of $87.18 implying 23% upside, but execution risks and premium valuation (P/E 38.1) temper enthusiasm. Key risks include profit margin compression and high debt levels despite improving leverage ratios. The stock faces near-term pressure from guidance concerns but maintains long-term growth potential.

Returns comparison

Trailing returns across standard periods

About ARK Genomic Revolution ETF

ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.

Read more on ARKG

About Carvana Co

Carvana Co is an e-commerce platform for buying and selling used cars. The company derives revenue from used vehicle sales, wholesale vehicle sales and other sales and revenues. The other sales and revenues include sales of loans originated and sold in securitization transactions or to financing partners, commissions received on VSCs and sales of GAP waiver coverage.

Read more on CVNA